logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 7 of 7 Items
Showing 1 - 7 of 7 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Commentary

Antivenoms for Snakebite Envenoming: What Is in the Research Pipeline?

Alirol E, Lechevalier P, Zamatto F, Chappuis F, Alcoba G,  et al.
2015-09-10 • PLOS Neglected Tropical Diseases
2015-09-10 • PLOS Neglected Tropical Diseases
Journal Article
|
Research

Drug-resistant tuberculosis clinical trials: proposed core research definitions in adults

Furin J, Alirol E, Allen E, Fielding K, Merle CS,  et al.
2016-03-01 • International Journal of Tuberculosis and Lung Disease
2016-03-01 • International Journal of Tuberculosis and Lung Disease
Drug-resistant tuberculosis (DR-TB) is a growing public health problem, and for the first time in decades, new drugs for the treatment of this disease have been developed. These new dru...
Journal Article
|
Research

Nifurtimox-eflornithine combination therapy for second-stage Gambiense human African trypanosomiasis: Médecins Sans Frontières experience in the Democratic Republic of the Congo

Alirol E, Schrumpf D, Amici Heradi J, Riedel A, de Patoul C,  et al.
2013-01-01 • Clinical Infectious Diseases
2013-01-01 • Clinical Infectious Diseases
BACKGROUND
Existing diagnostic and treatment tools for human African trypanosomiasis (HAT) are limited. The recent development of nifurtimox-eflornithine combination therapy (NECT) h...
Journal Article
|
Review

Rapid diagnostic tests for non-malarial febrile illness in the tropics

Chappuis F, Alirol E, d'Acremont V, Bottieau E, Yansouni CP
2013-05-01 • Clinical Microbiology and Infection
2013-05-01 • Clinical Microbiology and Infection
The recent roll-out of rapid diagnostic tests (RDTs) for malaria has highlighted the decreasing proportion of malaria-attributable illness in endemic areas. Unfortunately, once malaria i...
Journal Article
|
Review

Clinical Research in Neglected Tropical Diseases: The Challenge of Implementing Good Clinical (Laboratory) Practices

Ravinetto R, Alirol E, Mahendradhata Y, Rijal S, Lutumba P,  et al.
2016-11-03 • PLOS Neglected Tropical Diseases
2016-11-03 • PLOS Neglected Tropical Diseases
Journal Article
|
Research

Safety and effectiveness of sodium stibogluconate and paromomycin combination for the treatment of visceral leishmaniasis in Eastern Africa: results from a pharmacovigilance programme

Kimutai R, Musa AM, Njoroge SM, Omollo R, Alves F,  et al.
2017-03-01 • Clinical Drug Investigation
2017-03-01 • Clinical Drug Investigation
INTRODUCTION
In 2010, WHO recommended a new first-line treatment for visceral leishmaniasis (VL) in Eastern Africa. The new treatment, a combination of intravenous (IV) or intramuscu...
Journal Article
|
Short Report

High mortality among older patients treated with pentavalent antimonials for visceral leishmaniasis in East Africa and rationale for switch to liposomal amphotericin B

Chappuis F, Alirol E, Worku DT, Mueller YK, Ritmeijer KKD
2011-01-01 • Antimicrobial Agents and Chemotherapy
2011-01-01 • Antimicrobial Agents and Chemotherapy
Visceral leishmaniasis (VL; kala azar), a fatal disease if left untreated, is one of the most neglected tropical diseases....